Over the past five years, the world has experienced several outbreaks of virus, including Ebola virus, Zika virus, MERS-CoV and SARS-CoV-2 (novel coronavirus, formerly termed as 2019-nCoV). Faced with the potential threat of a pandemic, research institutions and companies in multiple countries and areas around the world have announced vaccine development plans. Creative Biostructure is a leading contract service vendor in the field of structural biology, and with the virus-like particle (VLP) platform we have established, we will support the development of coronavirus vaccine more quickly and accurately.